These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 33197548)

  • 1. Synthesis and antiproliferative evaluation of novel 8-cyclopentyl-7,8-dihydropteridin-6(5H)-one derivatives as potential anticancer agents.
    Li Q; Jian XE; Ma YF; Chen L; Huo XS; Wang Y; He RX; You WW; Zhao PL
    Bioorg Med Chem Lett; 2021 Jan; 31():127684. PubMed ID: 33197548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis and antiproliferative activity of novel substituted 2-amino-7,8-dihydropteridin-6(5H)-one derivatives.
    Li Q; Yang HK; Sun Q; You WW; Zhao PL
    Bioorg Med Chem Lett; 2017 Sep; 27(17):3954-3958. PubMed ID: 28789892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and preliminary antiproliferative activity of new pteridin-7(8H)-one derivatives.
    Li ZH; Zhao TQ; Liu XQ; Zhao B; Wang C; Geng PF; Cao YQ; Fu DJ; Jiang LP; Yu B; Liu HM
    Eur J Med Chem; 2018 Jan; 143():1396-1405. PubMed ID: 29113745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of pteridin-7(8H)-one analogues as highly potent cyclin-dependent kinase 4/6 inhibitors: Synthesis, structure-activity relationship, and biological activity.
    Li Q; Chen L; Ma YF; Jian XE; Ji JH; You WW; Zhao PL
    Bioorg Chem; 2021 Nov; 116():105324. PubMed ID: 34509794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis and biological evaluation of novel pteridinone derivatives possessing a hydrazone moiety as potent PLK1 inhibitors.
    Li Z; Xu L; Zhu L; Zhao Y; Hu T; Yin B; Liu Y; Hou Y
    Bioorg Med Chem Lett; 2020 Aug; 30(16):127329. PubMed ID: 32631534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, in vitro antiproliferative activity and apoptosis-inducing studies of 1-(3',4',5'-trimethoxyphenyl)-3-(2'-alkoxycarbonylindolyl)-2-propen-1-one derivatives obtained by a molecular hybridisation approach.
    Preti D; Romagnoli R; Rondanin R; Cacciari B; Hamel E; Balzarini J; Liekens S; Schols D; Estévez-Sarmiento F; Quintana J; Estévez F
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1225-1238. PubMed ID: 30141353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Syntheses of novel heterocycles as anticancer agents.
    Chauhan PM; Martins CJ; Horwell DC
    Bioorg Med Chem; 2005 May; 13(10):3513-8. PubMed ID: 15848764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and biological evaluation of novel 7-amino-[1,2,4]triazolo[4,3-f]pteridinone, and 7-aminotetrazolo[1,5-f]pteridinone derivative as potent antitumor agents.
    Hou Y; Zhu L; Li Z; Shen Q; Xu Q; Li W; Liu Y; Gong P
    Eur J Med Chem; 2019 Feb; 163():690-709. PubMed ID: 30572179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, and biological evaluation of novel combretastatin A-4 thio derivatives as microtubule targeting agents.
    Stefański T; Mikstacka R; Kurczab R; Dutkiewicz Z; Kucińska M; Murias M; Zielińska-Przyjemska M; Cichocki M; Teubert A; Kaczmarek M; Hogendorf A; Sobiak S
    Eur J Med Chem; 2018 Jan; 144():797-816. PubMed ID: 29291446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and preliminary biological evaluation of 5,8-dihydropteridine-6,7-diones that induce apoptosis and suppress cell migration.
    Geng PF; Wang CC; Li ZH; Hu XN; Zhao TQ; Fu DJ; Zhao B; Yu B; Liu HM
    Eur J Med Chem; 2018 Jan; 143():1959-1967. PubMed ID: 29133051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis, and biological evaluation of 4,5-dihydro-[1,2,4]triazolo[4,3-f]pteridine derivatives as novel dual-PLK1/BRD4 inhibitors.
    Wang NY; Xu Y; Xiao KJ; Zuo WQ; Zhu YX; Hu R; Wang WL; Shi YJ; Yu LT; Liu ZH
    Eur J Med Chem; 2020 Apr; 191():112152. PubMed ID: 32088495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis and antitumor evaluation of novel 5-methylpyrazolo[1,5-a]pyrimidine derivatives as potential c-Met inhibitors.
    Luo G; Ma Y; Liang X; Xie G; Luo Y; Zha D; Wang S; Yu L; Zheng X; Wu W; Zhang C
    Bioorg Chem; 2020 Nov; 104():104356. PubMed ID: 33142417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis and antiproliferative activity of novel 5-nitropyrimidine-2,4-diamine derivatives bearing alkyl acetate moiety.
    Zhao PL; Li YH; Yang HK; Chen P; Zhang B; Sun Q; Li Q; You WW
    Eur J Med Chem; 2016 Aug; 118():161-9. PubMed ID: 27128180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-proliferative potential of triphenyl substituted pyrimidines against MDA-MB-231, HCT-116 and HT-29 cancer cell lines.
    Ranjan Dwivedi A; Kumar V; Kaur H; Kumar N; Prakash Yadav R; Poduri R; Baranwal S; Kumar V
    Bioorg Med Chem Lett; 2020 Oct; 30(20):127468. PubMed ID: 32768647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis and antiproliferative activity of novel 2,4-diamino-5-methyleneaminopyrimidine derivatives as potential anticancer agents.
    Li Q; Chen L; Jian XE; Lv DX; You WW; Zhao PL
    Bioorg Med Chem Lett; 2021 Sep; 47():128213. PubMed ID: 34157389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and Antiproliferative Activity of New Thiosemicarboxamide Derivatives.
    Wu J; Guo Y; Chen J; Hu S; Sun K; Hu H; Fang M; Xue Y
    Chem Biodivers; 2021 Dec; 18(12):e2100671. PubMed ID: 34738709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis and biological evaluation of novel 3-alkylsulfanyl-4-amino-1,2,4-triazole derivatives.
    Zhao PL; Chen P; Li Q; Hu MJ; Diao PC; Pan ES; You WW
    Bioorg Med Chem Lett; 2016 Aug; 26(15):3679-83. PubMed ID: 27287368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of novel pyrimidine-based benzothiazole derivatives as potent cyclin-dependent kinase 2 inhibitors with anticancer activity.
    Diao PC; Lin WY; Jian XE; Li YH; You WW; Zhao PL
    Eur J Med Chem; 2019 Oct; 179():196-207. PubMed ID: 31254921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and biological evaluation of novel N-sulfonylamidine-based derivatives as c-Met inhibitors via Cu-catalyzed three-component reaction.
    Nan X; Zhang J; Li HJ; Wu R; Fang SB; Zhang ZZ; Wu YC
    Eur J Med Chem; 2020 Aug; 200():112470. PubMed ID: 32505087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological evaluation of novel pyrazolo[3,4-b]pyridines as cis-restricted combretastatin A-4 analogues.
    Jian XE; Yang F; Jiang CS; You WW; Zhao PL
    Bioorg Med Chem Lett; 2020 Apr; 30(8):127025. PubMed ID: 32063430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.